semaglutide cardiovascular trial SOUL: Oral Bests Usual Care in High-Risk Type 2 Diabetes Novo's obesity drug cuts risk

10.1182/blood-2008-03-040253 11 CarmelR.SarraiM

Un estudio (en ingls) similar publicado el ao pasado en Diabetes, Obesity and Metabolism encontr que cambiar de una dosis semanal de GLP-1 a una dosis cada dos semanas ayud a las personas a mantener aproximadamente el 75% de su prdida de peso

See the sources that passed Share this article Frequently Asked Questions What is AOD-9604 and how does it work for fat loss

It is the natural endpoint of what pharmacotherapy can achieve, and the results represent a transformation that most people could never sustain through diet and exercise alone

Maintenance dosing schedules are less often than the first doses, usually monthly